Skip to main content

Security report for angelinipharma.us

Angelini Pharma Inc · Healthcare · United States

Medium risk. 3 critical or high findings in Email security, GDPR outside view and 1 other check.

Security score

75/100

Risk levelMedium

0–100, higher is better. How it is calculated

Angelini Pharma Inc is a large healthcare company specializing in infection prevention, dialysis, and disinfectant products. It operates internationally with a strong presence in the USA and Europe, supported by a professional and content-rich website. The company is a subsidiary of Angelini S.p.a., a parent organization referenced on the site. The website demonstrates a mature digital infrastructure using modern JavaScript libraries and Piwik PRO analytics for user tracking and consent management. Privacy and cookie policies are comprehensive and GDPR compliant, reflecting good privacy practices. Security posture is moderate with HTTPS usage and cookie consent but lacks visible advanced security headers or explicit incident response information. Overall, the website is professional, trustworthy, and safe for general audiences, with no adult or questionable content detected.

Scanned

NIS2 and GDPR posture

GDPR outside view
68/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

3 findings rated critical or high. Fix these first.

  1. Email security

    SPF, DKIM and DMARC stop others sending email that looks like it comes from your domain, a common route to phishing and invoice fraud.

    • Critical

      No email authentication configured

      Domain is vulnerable to email spoofing

      What to do: Implement SPF, DKIM, and DMARC immediately

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching angelinipharma.us

This scan found 21 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
72
Security headers
90
Email security
60
DNS health
60
Network security
100
GDPR outside view
68
Average
75

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Angelini Pharma holds a solid market position in the healthcare sector, focusing on pharmaceutical and disinfectant products for infection control and dialysis. The business model revolves around manufacturing and distributing healthcare products across multiple countries, supported by localized websites and offices. The company leverages social media and video content to engage healthcare professionals and patients. Its parent company, Angelini S.p.a., provides corporate backing, enhancing credibility. The website's content and structure indicate a focus on compliance, education, and product promotion, targeting healthcare providers and patients. The presence of multiple country-specific domains suggests a broad international footprint and a well-established partnership ecosystem.

Security posture

The website employs HTTPS and a cookie consent mechanism, indicating baseline security and privacy compliance. However, no explicit security headers such as Content-Security-Policy or X-Frame-Options were detected, which could enhance protection against common web attacks. The use of third-party analytics (Piwik PRO) is privacy-conscious with anonymization options. No incident response or vulnerability disclosure information is publicly available, which could be improved to demonstrate security maturity. Overall, the security posture is adequate for a corporate healthcare site but could benefit from enhanced header configurations and transparency on security policies.

Recommendations

  1. Implement and enforce security headers like Content-Security-Policy, X-Frame-Options, and X-XSS-Protection to strengthen web security.
  2. Publish an incident response policy and provide dedicated security contact channels to improve transparency and readiness.
  3. Conduct regular audits of third-party scripts and analytics tools to mitigate potential vulnerabilities.
  4. Enhance SEO optimization by adding structured data (JSON-LD) and improving meta descriptions for better search visibility.
  5. Maintain and update privacy and cookie policies regularly to ensure ongoing GDPR and privacy compliance.

Contact details published on the site

Addresses
Legal name
Angelini Pharma Inc
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Angelini Pharma Inc
Description
Angelini Pharma is a healthcare company focused on infection prevention, dialysis, disinfectants, and related therapeutic areas. It offers disinfectant products and solutions supporting compliance across the care continuum.
Key services
Infection prevention products, Dialysis-related disinfectants, Healthcare disinfectants
Content quality
good
Branding
consistent

Technology

Stack
jQuery, Slick Slider, Magnific Popup, jQuery Validation, Piwik PRO Analytics
Performance
moderate
Mobile
good
Accessibility
good
SEO
basic

Security

Observed score
75/100
Good practices seen
  • Use of HTTPS (implied by URL https://)
  • Cookie consent mechanism implemented

Analytics and tracking

Services
Piwik PRO
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Piwik PRO
Marketing tools
Piwik PRO
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content and navigation.
  2. No WHOIS data available, indicating privacy protection or registry limitations.
  3. Comprehensive cookie and privacy policies with consent mechanisms implemented.
  4. Multiple social media official accounts linked.
  5. No security.txt or explicit incident response contact found.
  6. No visible security headers detected in HTML source.
  7. Use of modern JavaScript libraries and analytics tools.
  8. Content is healthcare focused, safe, and professional.
  9. No signs of adult or questionable content.
  10. Domain WHOIS data absence reduces transparency but not necessarily legitimacy.
Technical notes

Notes

The website uses a modern JavaScript stack including jQuery, Slick Slider, Magnific Popup, and jQuery Validation, providing a dynamic and interactive user experience. Piwik PRO analytics is integrated for user tracking with privacy controls. The site is mobile optimized with responsive design and accessible navigation. Performance is moderate, with some reliance on external font and script hosting. No CMS or hosting provider details are explicitly detected. The site could improve by adding structured data for enhanced SEO and implementing additional accessibility features. Overall, the technical infrastructure supports a professional and user-friendly healthcare website.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with angelinipharma.us. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review angelinipharma.us.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.